Postoperative Cox inhibitors and late prosthetic loosening - Suspicion increases!

Acta Orthopaedica

Volumn 76, Issue 6, 2005, Pages 733-734

  Aspenberg, Per ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

LOW MOLECULAR WEIGHT HEPARIN; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN; PROSTAGLANDIN SYNTHASE INHIBITOR; CYCLOOXYGENASE 2 INHIBITOR;

CLINICAL TRIAL; DRUG EFFECT; EDITORIAL; FOLLOW UP; HETEROTOPIC OSSIFICATION; HUMAN; NONHUMAN; POSTOPERATIVE PERIOD; PROSTHESIS LOOSENING; BONE DEVELOPMENT; HIP ARTHROPLASTY; NOTE; POSTOPERATIVE PAIN; PROSTHESIS FAILURE; RISK FACTOR;

ARTHROPLASTY, REPLACEMENT, HIP; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; HUMANS; OSTEOGENESIS; PAIN, POSTOPERATIVE; PROSTHESIS FAILURE; RISK FACTORS;

EID: 33644849652     PISSN: 17453674     EISSN: 17453682     Source Type: Journal    
DOI: 10.1080/17453670510045291     Document Type: Editorial

References (5)

1. Hilding M, Ryd L, Toksvig-Larsen S, Aspenberg P. Clodronate prevents prosthetic migration: a randomized radiostereometric study of 50 total knee patients. Acta Orthop Scand 2000; 71 (6): 553-7.
2. Persson P-E, Nilsson O S, Berggren A-M. Long-time outcome of total hip arthroplasty. Effects of non-steroidal anti-inflammatory drugs. Acta Orthop 2005; 76: 735-40.
3. Simon A M, Manigrasso M B and O'Connor J P. Cyclo-oxygenase 2 function is essential for bone fracture healing. J Bone Miner Res 2002; 17 (6): 963-76.
4. Street J T, McGrath M, O'Regan K, Wakai A, McGuinness A, Redmond H P. Thromboprophylaxis using a low molecular weight heparin delays fracture repair. Clin Orthop 2000; (381): 278-89.
5. Zhang X, Schwarz E M, Young D A, Puzas J E, Rosier R N, O'Keefe R J. Cyclooxygenase-2 regulates mesenchymal cell differentiation into the osteoblast lineage and is critically involved in bone repair. J Clin Invest 2002; 109 (11): 1405-15.